Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials

Fig. 4

Impact of combining transplantation timing and dosage of MSCs on LVEF. Time and dose was divided into three subgroups: <107 MSCs were injected within 1 week of AMI, >107 MSCs were injected within 1 week of AMI, and >107 MSCs were injected after 1 week of AMI. CI confidence interval, IV inverse variance, MSC mesenchymal stromal cell, SD standard deviation

Back to article page